Nordic Life Science cares about your privacy

The BioInnovation Institute (BII) and GU Ventures (GUV) are collaborating to strengthen the regions' competitiveness in life science, a project funded by Interreg Öresund-Kattegat-Skagerrak and Region Västra Götaland.

Europe has the science. What it doesn't have is the capital, and industry leaders warn that gap is pushing the region's most promising biotechs to scale up in the US instead.

Norwegian biotech Circio Holding has entered a research collaboration with US-based Full Circles Therapeutics to combine their respective circular nucleic acid platforms, aiming to build non-viral, re-dosable in vivo cell therapies as an alternative to conventional approaches like CAR-T.

Finnish medtech company Koite Health has entered a research collaboration with Associated Brånemark Osseointegration Centers (ABOC), the global implantology network built on Professor Per-Ingvar Brånemark's osseointegration research, to study how at-home antibacterial care can be integrated into structured preventive protocols for dental implant patients.

BioArctic and Mesenkia Therapeutics have signed a research collaboration agreement to explore a novel antibody-based approach for glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, where effective delivery of large molecules to the brain remains a major challenge.

The Lundbeck Foundation has awarded DKK 78 million to a pan-Nordic centre that will focus on research into the glymphatic system.

Navinci Diagnostics has initiated a collaboration with BrainZell to explore the use of Navinci’s in situ Proximity Ligation Assay technology in human brain organoid models to support relevant studies of biology and drug response.